Skip to content

NETosis in burn wound patients

NETosis in burn wound patients - NETosis in burns/NIB

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54153
Enrollment
20
Registered
2023-04-14
Start date
2023-11-13
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brandwonden NETosis and thrombosis formation

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients: - >= 18 years  - Acute burns - Competent and temporarily incompetent patients - Informed Consent by patient or the legal representative - Admitted to the Burn Center of the Red Cross Hospital in Beverwijk, who are  expected to be admitted at least until the second measurement moment - No acute psychiatric disorders - Sufficient Dutch proficiency Healthy volunteers: - >= 18 years  - Competent  - Informed Consent  - Sufficient Dutch proficiency

Exclusion criteria

Exclusion criteria: Patients:  - Known underlying diseases: cancer, immune deficiency, hypertension,  complement, thrombosis disorder. Healthy volunteers: - Pregnancy or lactating - Any medication except contraceptives - Known underlying diseases: cancer, immune deficiency, hypertension,  complement, thrombosis disorder.

Design outcomes

Primary

MeasureTime frame
Burn wound severity will be determined at day of admission (day 0/1), day 2-5 post-burn and at day of surgery (if applicable) or day 10 - 20 post-burn by clinical evaluation, Laser Doppler Imaging (LDI) (not day 10 - 20), and (immuno)histochemical analyses in burn skin biopsies. In biopsies taken at the same time points the occurrence of intra-microvascular thrombi and NETosis will be quantified. In addition, in blood samples collected simultaneously with clinical routine lab up to day 30 post-burn, the levels of cfDNA/NETs, DNase1 and endogenous pdC1inh will be quantified. MBL serum levels will be examined in relation to bacterial presence and wound healing. From healthy volunteers only blood samples will be collected for the quantification of cfDNA/NETs, DNase1 and endogenous pdC1inh levels.

Secondary

MeasureTime frame
Correlations/associations between wound deepening, thrombosis/NETosis, levels of cfDNA/NETs, DNase1 and endogenous pdC1inh will be investigated. In addition, associations of thrombosis/NETosis with burn wound parameters and characteristics of the patients collected from the medical file e.g. wound size (% burned of TBSA), wound closure time, co-morbidities, inhalation trauma, graft take, length of stay, number of surgical procedures will also be investigated.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)